Puncture force tester of medical injection needle

A 5.7-inch (120 × 90) single color LCD touch screen and Chinese menu display are used in the needle puncture force simulation skin tester. Nominal specification, pipe wall, test times, pressurization, upward, downward, time, calibration. The menu on the LCD is controlled by the keyboard, and the test data is printed on board. Real time display of puncture force and peak force data can display puncture force and five peak forces of F. The instrument is designed and manufactured in accordance with gb15811 sterile injection needle for single use.
Principle:
A puncture force test device is used to evaluate the puncture force of the injection needle through the peak force measured when simulating the skin at a specified speed.
Parameters:
Nominal specification: 0.3-1.2mm;
Test range: 0.10-5.00n, accuracy: ± 0.01N;
Moving speed: 100mm / min;
(free) simulated skin: polyurethane membrane material, complying with gb15811 standard;
Printing method: 8 times, 13 times or 20 times of test data, average puncture force and deviation value can be printed each time;
Net weight: 11kg;
Boundary dimension: 400 × 290 × 240 (mm).

Shanghai kerang technology co., ltd is located in Shanghai City, China, and was established in 2018.It is a company specializing in the field of automation technology: technology development, technology transfer, technical consultation and technical service; installation, design, commissioning and maintenance of automation equipment; and other high-tech enterprises. And have strong R & D capabilities in the field of test instrument industry. The testing equipment developed by the company is widely used in many industries such as electronics, home appliances, etc.

We have strong technical reserves and solid technical strength, especially in the field of environmental testing equipment or product online monitoring. The newly developed products are used in aerospace, aerospace, nuclear industry and other projects.

Looking forward to your inquiry and negotiation.